
10
Investment Adviser’s Report – Unquoted Portfolio
We present a review of the unquoted investment
portfolio for the year ended 31 March 2022.
At 31 March 2022, the unquoted portfolio of 56
investments were valued at £59.3 million. 36 of
these with a value of £40.7 million are unquoted
growth companies and 20 are unquoted yield
focused companies with a value of £18.6 million.
Unquoted Growth
Investment activity
During the period, there was a high level of
realisation and investment activity with £4.3
million of proceeds generated from exits and a
total of £3.1 million invested into unquoted
growth companies.
Three new investments were added to the
unquoted growth portfolio:
DSTBTD Limited (£775,000) (trading as
Distributed) is a software development company
that helps to build a flexible and effective
workforce. The company enables enterprises to
build software and technology solutions by
sourcing software developers, onboarding them,
and tracking their performance whilst also being
responsible for the outcomes of the technology
solutions, providing benefits to both the
developers and the enterprise customers.
Bulbshare Limited (£749,000) is a company that
enables brands to build communities from their
existing customers, gathering consumer insights
whilst offering a superior user experience for
those customers. This feedback results in more
engaged customers and builds value for the brand
from user generated content, reviews, and
endorsements.
DiA Imaging Analysis Limited (£208,000) is a
leading provider of Artificial Intelligence based
solutions for ultrasound analysis. The investment
will enable DiA to expand on its portfolio of FDA-
cleared and CE-marked AI-based ultrasound
solutions which enable clinicians to identify
medical abnormalities with speed and accuracy.
Follow on investments totalling £1.4 million were
made into eight companies, most notably
Cambridge Touch Technologies Limited
(£500,000), Cambridge Respiratory Limited
(£250,000) and E-Fundamentals (Group) Limited
(£166,000).
Details of the investment realisations during the
year are set out on page 20. Total proceeds of
£4.3 million were generated from 7 investments,
producing a gain over holding value of £1.9
million, although representing a loss over cost of
£3.2 million.
The largest gain in the period related to Xupes
Limited, a pre-owned luxury goods retailer
specialising in designer watches, handbags, and
jewellery. The investment was sold in October
2021, returning £1.6 million, resulting in a gain
over the opening value of £1.2 million, however,
a loss over cost of £637,000.
Curo Compensation Limited, the provider of a
human resources software service, was sold in
the period, generating proceeds of £1.6 million,
resulting in a loss over cost of £59,000, although
this was a gain over the previous holding value of
£509,000.
Avid Technology Group Limited, a manufacturer
of electrified ancillary equipment for internal
combustion engines, was sold during the period,
generating proceeds of £429,000. The
investment had previously been fully provided
against, so this represented a gain of £429,000 in
the period, although it should be noted that this
was a disappointing overall loss against the
original cost of £1.4 million.
Further deferred consideration was received from
BridgeU Limited in relation to the exit in 2021,
producing further proceeds of £143,000 in the
year.
JRNI Limited, a business to business (B2B)
software platform that enables companies to
offer online appointments and event bookings for
their customers and staff, exited, producing a gain
over carrying value and original cost of £23,000.
It is disappointing to report that Exonar Limited
and Glownet Limited both exited in full for nil
proceeds during the year, resulting in a combined
loss over original cost of £1.3 million and a
realised loss over carrying value of £379,000.
Portfolio valuation
The unquoted portfolio, on the whole, performed
well over the period, resulting in a total unrealised
gain of £3.6 million in the period, including
unrealised foreign exchange gains of £511,000.
£472,000 of the £3.6 million gain was recognised
within the unquoted yield focus portfolio, further
detail can be found on the following pages. The
remaining £3.1 million was recognised within the
unquoted growth portfolio. The most significant
movements are noted below:
The largest gain in value was in Ayar Labs, Inc, the
developer of components for high performance
computing and data centre applications. At the
period end, the company was uplifted by £1.4
million, including the impact of foreign exchange.
This revaluation is the result of a calibration to
the price set by a recent funding round.